Aug. 07, 2019News & Opinions
GlaxoSmithKline (GSK) has completed its transaction with Pfizer to combine their consumer healthcare businesses into a joint venture. GSK owns 68% of the combined business with Pfizer owning 32%.
Oct. 13, 2017News & Opinions
Pfizer is reviewing the future of its Consumer Healthcare division. The US drug major said it is considering a range of options, including a full or partial separation through a spin-off, sale or other transaction, or even ultimately ...
Feb. 15, 2017News & Opinions
French pharmaceutical producer Sanofi has agreed to sell five consumer healthcare products in certain European territories to compatriot drugmaker Ipsen for €83 million. The cash-and-credit deal, expected to complete in this ...
Sep. 21, 2016News & Opinions
Emma Walmsley has been named to succeed Andrew Witty as CEO of the UK’s largest drugmaker on his retirement at the end of March 2017. Prior to that, the 47-year-old, who will have the distinction of being the first woman to run a ...
Apr. 06, 2016News & Opinions
With its expanded consumer healthcare portfolio in mind following the $14 billion acquisition of the relevant Merck & Co business in 2004, Bayer is striving to lift its profile in the US, the world's biggest drug market.
Dec. 16, 2015News & Opinions
French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have begun exclusive negotiations toward a swap of Sanofi’s subsidiary Merial, a manufacturer of animal health products, for Boehringer’s consumer ...
May. 30, 2014News & Opinions
Swiss food group Nestle has accelerated a push into the fast-growing skincare market, buying the rights to several injectable treatments for facial wrinkles and lines from Valeant Pharmaceuticals International for $1.4 billion.
May. 29, 2014News & Opinions
As expected, Canadian drugmaker Valeant Pharmaceuticals International raised the cash component of its offer for Botox manufacturer Allergan on May 28. Its new offer values the US firm at $49.44 billion.
May. 07, 2014News & Opinions
As expected, Germany's Bayer has emerged as the winner of the race to acquire U.S. Merck's consumer care business. The $14.2 billion deal announced on May 5 is expected to close in the second half of 2014.
May. 05, 2014News & Opinions
U.S. drugmaker Pfizer increased its offer for the UK's AstraZeneca on May 2 to £63 billion ($106 billion) but the proposal, which would create the world's biggest pharmaceuticals company, was rejected.
The latest information directly via newsletter.